World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
70
Citations
24595
World Ranking
2378
National Ranking
89

Yoshihiro Hayakawa publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yoshihiro Hayakawa sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 190 publications — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yoshihiro Hayakawa D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yoshihiro Hayakawa sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Yoshihiro Hayakawa is affiliated with the Aichi Institute of Technology in Japan. The primary focus of their research lies in the fields of Biochemistry, Genetics and Molecular Biology, and Medicine.

Their work shows a particular emphasis on several subfields, including Molecular Biology, Immunology, Oncology, Pharmacology, and Spectroscopy. Within these areas, the main topics covered are Immune Cell Function and Interaction, Analytical Chemistry and Chromatography, Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Natural product bioactivities and synthesis, and Ginger and Zingiberaceae research.

Yoshihiro Hayakawa has a substantial record of publications in various venues. The most frequent publication venues include:

  • Cancer Science
  • Scientific Reports
  • Biological and Pharmaceutical Bulletin
  • Journal of Natural Medicines
  • Journal of Chromatography A

Frequent co-authors who have collaborated extensively with Yoshihiro Hayakawa are:

  • Soichiro Sasaki
  • Satoru Yokoyama
  • Takeshi Susukida
  • Hideyoshi Harashima
  • Hiroaki Sakurai

Recent published papers include:

  • STING agonist loaded lipid nanoparticles overcome anti-PD-1 resistance in melanoma lung metastasis via NK cell activation, 2021, Journal for ImmunoTherapy of Cancer
  • SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis, 2021, Cancer Research
  • Inhibition of cell-intrinsic NF-κB activity and metastatic abilities of breast cancer by aloe-emodin and emodic-acid isolated from Asphodelus microcarpus, 2021, Journal of Natural Medicines
  • Combined nano cancer immunotherapy based on immune status in a tumor microenvironment, 2022, Journal of Controlled Release
  • Pharmacological targeting of natural killer cells for cancer immunotherapy, 2020, Cancer Science

Best Publications

  • STING is a direct innate immune sensor of cyclic di-GMP

    Dara L. Burdette;Kathryn M. Monroe;Katia Sotelo-Troha;Jeff S. Iwig

  • New aspects of natural-killer-cell surveillance and therapy of cancer

    Mark J. Smyth;Yoshihiro Hayakawa;Kazuyoshi Takeda;Hideo Yagita

  • Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Mark J. Smyth;Nobuhiko Kayagaki

  • Activation of NK cell cytotoxicity.

    Mark J. Smyth;Erika Cretney;Janice M. Kelly;Jennifer A. Westwood

  • CD27 Dissects Mature NK Cells into Two Subsets with Distinct Responsiveness and Migratory Capacity

    Yoshihiro Hayakawa;Mark J. Smyth

  • The Innate Immune DNA Sensor cGAS Produces a Noncanonical Cyclic Dinucleotide that Activates Human STING

    Elie J. Diner;Dara L. Burdette;Stephen C. Wilson;Kathryn M. Monroe

  • The N-Ethyl-N-Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic Dinucleotides

    John Demian Sauer;Katia Sotelo-Troha;Jakob Von Moltke;Kathryn M. Monroe

  • Critical contribution of liver natural killer T cells to a murine model of hepatitis.

    Kazuyoshi Takeda;Yoshihiro Hayakawa;Luc Van Kaer;Hironori Matsuda

  • Critical Role for Tumor Necrosis Factor–related Apoptosis-inducing Ligand in Immune Surveillance Against Tumor Development

    Kazuyoshi Takeda;Mark J. Smyth;Erika Cretney;Yoshihiro Hayakawa

  • CD4+CD25+ T Regulatory Cells Suppress NK Cell-Mediated Immunotherapy of Cancer

    Mark J. Smyth;Michele W. L. Teng;Jeremy Swann;Konstantinos Kyparissoudis

  • Cytokines in cancer immunity and immunotherapy

    Mark J. Smyth;Erika Cretney;Michael H. Kershaw;Yoshihiro Hayakawa

  • Nature's TRAIL: On a path to cancer immunotherapy

    Mark J Smyth;Kazuyoshi Takeda;Yoshihiro Hayakawa;Jacques J Peschon

  • Differential antitumor immunity mediated by NKT cell subsets in vivo.

    Nadine Y. Crowe;Jonathan M. Coquet;Stuart P. Berzins;Konstantinos Kyparissoudis

  • NKG2D function protects the host from tumor initiation

    Mark J. Smyth;Jeremy Swann;Erika Cretney;Nadeen Zerafa

  • IL-21 Induces the Functional Maturation of Murine NK Cells

    Jason Brady;Yoshihiro Hayakawa;Mark J. Smyth;Stephen L. Nutt

  • Type I IFN contributes to NK cell homeostasis, activation, and antitumor function.

    Jeremy B Swann;Yashihiro Hayakawa;Nadeen Zerafa;Kathleen Cf Sheehan

  • NKT cells — conductors of tumor immunity?

    Mark J Smyth;Nadine Y Crowe;Yoshihiro Hayakawa;Kazuyoshi Takeda

  • Glycolipid Antigen Drives Rapid Expansion and Sustained Cytokine Production by NK T Cells

    Nadine Y Crowe;Adam P Uldrich;Konstantinos Kyparissoudis;Kirsten Jenna Louise Hammond

  • NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation.

    Nicholas D. Huntington;Nicholas D. Huntington;Hy Tabarias;Hy Tabarias;Kirsten Fairfax;Kirsten Fairfax;Jason Brady

  • The Dark Side of IFN-γ: Its Role in Promoting Cancer Immunoevasion

    Marija Mojic;Kazuyoshi Takeda;Yoshihiro Hayakawa

  • A nonclassical non-Vα14Jα18 CD1d-restricted (type II) NKT cell is sufficient for down-regulation of tumor immunosurveillance

    Masaki Terabe;Jeremy Swann;Elena Ambrosino;Pratima Sinha

  • TRAIL and its receptors as targets for cancer therapy.

    Hideo Yagita;Kazuyoshi Takeda;Yoshihiro Hayakawa;Mark J. Smyth

Frequent Co-Authors

Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Ikuo Saiki
Ikuo Saiki University of Toyama
Kazuyoshi Takeda
Kazuyoshi Takeda Juntendo University
Hideo Yagita
Hideo Yagita Juntendo University
Ko Okumura
Ko Okumura Juntendo University
Dale I. Godfrey
Dale I. Godfrey University of Melbourne
Hiroaki Sakurai
Hiroaki Sakurai University of Toyama
Tatsuro Irimura
Tatsuro Irimura Juntendo University
Stephen L. Nutt
Stephen L. Nutt Walter and Eliza Hall Institute of Medical Research
Mariapia A. Degli-Esposti
Mariapia A. Degli-Esposti Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related online degrees can open diverse career paths in healthcare and research. Many professionals begin with foundational programs such as online RN programs for non nurses, providing essential clinical skills and knowledge for entry into nursing roles.

Advancing further, accelerated pathways like those featured in accelerated NP program options allow motivated students to swiftly transition into nurse practitioner roles. Specialized tracks, such as acnp programs, cater specifically to those aiming to work in acute care settings, expanding clinical expertise relevant to immunology-related conditions.

Understanding compensation is also vital when choosing a path. Insight into dnp salary by specialty highlights how advanced practice roles in nursing and immunology-related fields can offer rewarding financial prospects across different states.

Overall, integrating immunology studies with these online nursing degrees and certifications can pave the way for impactful careers in patient care, research, and clinical leadership.

Best Scientists Citing Yoshihiro Hayakawa

Trending Scientists

Recently Published Articles